Skip to Content

Addyi - Why is it not to be used in postmenopausal women? I think we are the ones who need it most!

Responses (1)

paulyboy 8 Sep 2015

At present, Addyi is only FDA approved for use in premenopausal women with hypoactive sexual desire disorder (HSDD).

There has been a study called the SNOWDROP trial which assessed the effectiveness of flibanserin (Addyi) in over 900 postmenopausal women with HSDD. The results were positive, with flibanserin (Addyi) demonstrating a significant improvement in sexual desire compared to a placebo.

Doctors may still prescribe a drug for an indication for which it is not approved. This is known as "off-label" drug use. If you are postmenopausal and suffer from hypoactive sexual desire disorder, talk to your doctor about your options.

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions